Cargando…

The temporal context of oral anticoagulation outcome in atrial fibrillation

Detalles Bibliográficos
Autores principales:	Fender, Anke C., Dobrev, Dobromir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157463/ https://www.ncbi.nlm.nih.gov/pubmed/35663453 http://dx.doi.org/10.1016/j.ijcha.2022.101051

Ejemplares similares

Anticoagulation in difficult settings RELOADed: Evidence for applicability of direct oral anticoagulants in patients with atrial fibrillation, renal impairment and cancer
por: Fender, Anke C., et al.
Publicado: (2019)

Breaking bad: Higher risk of osteoporosis with vitamin K antagonists compared to direct oral anticoagulants in patients with atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2020)

Direct oral anticoagulation and severe obesity – One size fits all?
por: Fender, Anke C., et al.
Publicado: (2021)

Recent highlights on specific aspects of oral anticoagulation in difficult clinical scenarios from the International Journal of Cardiology Heart & Vasculature
por: Fender, Anke C., et al.
Publicado: (2023)

Recent highlights from the International Journal of Cardiology Heart & Vasculature on challenges for adequate stroke prevention in patients with atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2023)

Bound to bleed: How altered albumin binding may dictate warfarin treatment outcome
por: Fender, Anke C., et al.
Publicado: (2019)

Repurposing traditional immunomodulators to target the inflammatory burden of atherosclerosis()
por: Fender, Anke C., et al.
Publicado: (2020)

Contemporary plaque imaging for risk stratification of coronary artery disease: Are we getting there?
por: Fender, Anke C., et al.
Publicado: (2020)

Coronary clot composition after myocardial infarction: Thrombus age matters
por: Fender, Anke C., et al.
Publicado: (2019)

Pleiotropic actions of ticagrelor versus clopidogrel – Do molecular differences translate into superior clinical efficacy after myocardial infarction?
por: Fender, Anke C., et al.
Publicado: (2020)

The virtual patient – Estimating the health utility of aspirin in simulated populations
por: Fender, Anke C., et al.
Publicado: (2021)

Childhood infection and modern malnutrition: Do childhood infections create an inflammatory foundation for atherosclerosis in adult life?
por: Fender, Anke C., et al.
Publicado: (2021)

Soluble fibrin monomer complex as a candidate sentinel for adverse events in patients with heart failure
por: Fender, Anke C., et al.
Publicado: (2021)

Evolving insights into the pleiotropic cardioprotective mechanisms of SGLT2 inhibitors
por: Fender, Anke C., et al.
Publicado: (2023)

Recent highlights on the mechanistic basis of cardiovascular remodeling from the International Journal of Cardiology Heart & Vasculature
por: Fender, Anke C., et al.
Publicado: (2023)

Double Jeopardy: Will the new trials tell us how to manage patients with atrial fibrillation and coronary artery disease?
por: Wakili, Reza, et al.
Publicado: (2019)

Outcome of atrial fibrillation ablation in pulmonary hypertension: Is pulmonary hypertension a modifiable risk factor?
por: Linz, Dominik, et al.
Publicado: (2019)

Altered Atrial Metabolism: An Underappreciated Contributor to the Initiation and Progression of Atrial Fibrillation
por: Ghezelbash, Shokoufeh, et al.
Publicado: (2015)

Bayesian network analyses in atrial fibrillation – A path to better therapies?()
por: Heijman, Jordi, et al.
Publicado: (2019)

Fat chance for POAF? Pericardial adipose tissue and the arrhythmogenic substrate for postoperative atrial fibrillation
por: Gawałko, Monika, et al.
Publicado: (2022)

Botulinum toxin for prevention of post-operative atrial fibrillation
por: Saljic, Arnela, et al.
Publicado: (2023)

Genome-wide association studies of atrial fibrillation: Finding meaning in the life of risk loci
por: Sutanto, Henry, et al.
Publicado: (2019)

Atrial fibrillation in sub-Saharan Africa: The knowns and unknowns?
por: Linz, Dominik, et al.
Publicado: (2019)

Gut-microbiota derived TMAO: A risk factor, a mediator or a bystander in the pathogenesis of atrial fibrillation?
por: Gawałko, Monika, et al.
Publicado: (2021)

Recent highlights on thrombosis and hemostasis from the International Journal of Cardiology: Heart & Vasculature
por: Fender, Anke C., et al.
Publicado: (2022)

Oral Anticoagulants for Atrial Fibrillation Patients with Active Cancer
por: Kim, Do Young, et al.
Publicado: (2018)

The gut microbial-derived metabolite trimethylamine N-oxide: A missing link between lifestyle-components and atrial fibrillation?
por: Gawałko, Monika, et al.
Publicado: (2020)

Sleep apnea and atrial fibrillation: Update 2020
por: Linz, Dominik, et al.
Publicado: (2020)

Emerging Antiarrhythmic Drugs for Atrial Fibrillation
por: Saljic, Arnela, et al.
Publicado: (2022)

Recurrence of atrial fibrillation following non-cardiac surgery or acute illness: A common but rarely detected complication
por: Barrios Espinosa, Cristian, et al.
Publicado: (2020)

Safety and efficacy of vernakalant for acute cardioversion of atrial fibrillation: an update
por: Tsuji, Yukiomi, et al.
Publicado: (2013)

Personalized management of sleep apnea in patients with atrial fibrillation: An interdisciplinary and translational challenge
por: Linz, Dominik, et al.
Publicado: (2021)

Antiarrhythmic drugs for atrial fibrillation: Imminent impulses are emerging
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2018)

Highlights from the International Journal of Cardiology Heart & Vasculature: Heart failure, atrial fibrillation, coronary artery disease and myocardial infarction
por: Linz, Dominik, et al.
Publicado: (2019)

Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
por: Heijman, Jordi, et al.
Publicado: (2013)

Surgery-related cardiac stress: A susceptibility test of late atrial fibrillation recurrence?
por: Gawałko, Monika, et al.
Publicado: (2020)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Stroke prevention within primary care: management of atrial fibrillation using oral anticoagulation
por: Lotufo, Paulo Andrade
Publicado: (2018)

Calcium dysregulation in atrial fibrillation: the role of CaMKII
por: Heijman, Jordi, et al.
Publicado: (2014)

Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology
por: Dobrev, Dobromir, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dfvab5dd7isjcr0kqvdcvor5p0